IL1RN Protein (AA 26-177)
-
- Antigène Voir toutes IL1RN Protéines
- IL1RN (Interleukin 1 Receptor Antagonist (IL1RN))
- Type de proteíne
- Recombinant
- Activité biologique
- Active
- Attributs du protein
- AA 26-177
-
Origine
- Humain
-
Source
- HEK-293T Cells
- Attributs du produit
- ED50 < 0.1 μg /mL, measured in a neutralization assay using D10S cells in the presence of 50pg/mL Human IL-1a.
- Pureté
- > 95 % as analyzed by SDS-PAGE and HPLC.
- niveau d'endotoxine
- < 0.2 EU/μg, determined by LAL method.
- Top Product
- Discover our top product IL1RN Protéine
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstituted in ddH2O or PBS at 100 μg/mL.
- Buffer
- Lyophilized after extensive dialysis against PBS.
- Stock
- -80 °C
- Stockage commentaire
- Lyophilized recombinant human IL-1 Receptor Antagonist remains stable up to 6 months at -80 °C from date of receipt. Upon reconstitution, Human IL-1 Receptor Antagonist should be stable up to 1 week at 4 °C or up to 2 months at -20 °C.
- Date de péremption
- 6 months
-
- Antigène
- IL1RN (Interleukin 1 Receptor Antagonist (IL1RN))
- Autre désignation
- IL-1 Receptor Antagonist (IL1RN Produits)
- Synonymes
- DIRA Protein, ICIL-1RA Protein, IL-1RN Protein, IL-1ra Protein, IL-1ra3 Protein, IL1F3 Protein, IL1RA Protein, IRAP Protein, MVCD4 Protein, IRAP1 Protein, IL1RN Protein, IL-1RA Protein, F630041P17Rik Protein, interleukin 1 receptor antagonist Protein, interleukin 1 receptor antagonist-like Protein, IL1RN Protein, Il1rn Protein, IL1RNL Protein
- Sujet
-
IL-1 Receptor Antagonist, also known as IL-1RA, ICIL-1RA, IRAP and IL-1RN, is a member of the interleukin 1 cytokine family. It is expressed by monocytes, neutrophils, macrophages, epithelial cells and fibroblasts. IL-1RA inhibits the activity of both IL-1alpha and IL-1beta, and modulates a variety of IL-1 related immune and inflammatory responses. It inhibits the activity of IL-1 by binding to the receptor IL-1R1 and preventing its association with the coreceptor IL-1RAP for signaling. Clinical studies are being conducted to investigate the use of IL-1RA in the treatment of sepsis, rheumatoid arthritis and chronic myelogenous leukemia.
Synonyms: IL-1RA, ICIL-1RA, IRAP, IL-1RN - Poids moléculaire
- 18-23 kDa, observed by reducing SDS-PAGE.
- UniProt
- P18510
- Pathways
- Signalisation NF-kappaB, Hormone Transport, Cancer Immune Checkpoints
-